ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010
Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.
- Exploring disparities in adherence to colorectal cancer clinical practice guidelines and associated survival outcomes: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Receipt of recommended surveillance among colorectal cancer survivors: a systematic review.Journal of cancer survivorship : research and practice · 2013Pooled it
- An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.American journal of preventive medicine · 2020Trial
- Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.Journal of cancer survivorship : research and practice · 2013Trial
- Timeliness of Colorectal Cancer Care in Veterans: The Role of Travel Distance.Cancer reports (Hoboken, N.J.) · 2026Article
- Quality of Care in Veterans Affairs Health Care System In-Person and National TeleOncology Service-Delivered Care.JCO oncology practice · 2025Article
- Colorectal Cancer Characteristics and Mortality From Propensity Score-Matched Cohorts of Urban and Rural Veterans.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025Article
- Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer.Annals of the American Thoracic Society · 2025Article
- Serving Those Who Served: Enhancing Colorectal Surgery Care for Veterans.Clinics in colon and rectal surgery · 2025Review
- Summary of Veterans Health Administration Cancer Data Sources.Journal of registry management · 2024Article
- Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.JAMA network open · 2023Article
- Veterans Health Administration National TeleOncology Service.JCO oncology practice · 2023Article
- Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer.Cancer medicine · 2022Article
- Colorectal cancer adjuvant chemotherapy trends among a nonelderly veteran cohort at a southern veterans health administration.Cancer reports (Hoboken, N.J.) · 2022Article
- Society for Surgery of the Alimentary Tract Health Care Quality and Outcomes Committee Webinar: Addressing Disparities.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022Article
- Association of Adherence to Quality Metrics with Recurrence or Mortality among Veterans with Colorectal Cancer.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021Article
- Article
- Risk factors for thick melanoma among veterans: A cross-sectional study.Journal of the American Academy of Dermatology · 2021Article
- Article
- Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.Hepatology (Baltimore, Md.) · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors at 1 institution in 1 country.
Funding
Abstract
purposeThe Veterans Affairs (VA) healthcare system treats approximately 3% of patients with cancer in the United States each year. We measured the quality of nonmetastatic colorectal cancer (CRC) care in VA as indicated by concordance with National Comprehensive Cancer Network practice guidelines (six indicators) and timeliness of care (three indicators). PATIENTS AND
methodsA retrospective medical record abstraction was done for 2,492 patients with incident stages I to III CRC diagnosed between October 1, 2003, and March 31, 2006, who underwent definitive CRC surgery. Patients were treated at one or more of 128 VA medical centers. The proportion of patients receiving guideline-concordant care and time intervals between care processes were calculated.
resultsMore than 80% of patients had preoperative carcinoembryonic antigen determination (ie, stages II to III disease) and documented clear surgical margins (ie, stages II to III disease). Between 72% and 80% of patients had appropriate referral to a medical oncologist (ie, stages II to III disease), preoperative computed tomography scan of the abdomen and pelvis (ie, stages II to III disease), and adjuvant fluorouracil-based chemotherapy (ie, stage III disease). Less than half of patients with stages I to III CRC (43.5%) had a follow-up colonoscopy 7 to 18 months after surgery. The mean number of days between major treatment events included the following: 26.6 days (standard deviation [SD], 38.2; median, 20 days) between diagnosis and initiation of treatment (in stages II to III disease); 64.8 [corrected] days (SD, 54.9; median, 50 days) between definitive surgery and start of adjuvant chemotherapy (in stages II to III disease); and 444.2 [corrected] days (SD, 182.1; median, 393 days) between definitive surgery and follow-up colonoscopies (in stages I to III disease).
conclusionAlthough there is opportunity for improvement in the area of cancer surveillance, the VA performs well in meeting established guidelines for diagnosis and treatment of CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.